Back to Search Start Over

Neuroinfections and antimicrobials: do we need new molecules or new strategies?

Authors :
Kalavsky E
Kisac P
Huttova M
Benca J
Krcmery V
Source :
Neuro endocrinology letters [Neuro Endocrinol Lett] 2007 Jun; Vol. 28 Suppl 2, pp. 38-9.
Publication Year :
2007

Abstract

Within last 15 years, analyzing patterns of etiology and resistance in organisms causing neuroinfections, emergence of resistance has been observed in Slovakia in S. haemolyticus to teicoplanin (11%), Ps. aeruginosa and A. baumannii to meropenem (20%) and Candida spp. (non-albicans Candida spp.) to fluconazol (20%). There are no new antibiotics against carbapenem resistant Ps. aeruginosa and Acinetobacter baumannii.

Subjects

Subjects :
Brain Diseases drug therapy
Brain Diseases microbiology
Candidiasis drug therapy
Cross Infection microbiology
Fluconazole therapeutic use
Humans
Meningitis microbiology
Meropenem
Pseudomonas Infections drug therapy
Staphylococcal Infections drug therapy
Teicoplanin therapeutic use
Thienamycins therapeutic use
Anti-Infective Agents therapeutic use
Cross Infection drug therapy
Drug Resistance, Microbial
Meningitis drug therapy

Details

Language :
English
ISSN :
0172-780X
Volume :
28 Suppl 2
Database :
MEDLINE
Journal :
Neuro endocrinology letters
Publication Type :
Academic Journal
Accession number :
17558378

Tools

Authors Abstract Subjects Details